1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Immunochemistry Instruments and Reagents Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Immunochemistry Instruments and Reagents Market Revenue and Volume, by Product
8.1.1. Instruments
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Reagents & Kits
8.1.2.1. Market Revenue and Volume Forecast
9.1. Immunochemistry Instruments and Reagents Market Revenue and Volume, by Technology
9.1.1. Chemiluminescence Immunoassay (CLIA)
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Enzyme-linked Immunosorbent Assay (ELISA)
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Radioimmunoassay (RIA)
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Fluorescence Immunoassay
9.1.4.1. Market Revenue and Volume Forecast
10.1. Immunochemistry Instruments and Reagents Market Revenue and Volume, by Application
10.1.1. Infectious Diseases
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Oncology
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Endocrinology
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Cardiology
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Autoimmune Diseases
10.1.5.1. Market Revenue and Volume Forecast
11.1. Immunochemistry Instruments and Reagents Market Revenue and Volume, by End-Use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Diagnostic Laboratories
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Academic & Research Institutes
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Blood Banks
11.1.4.1. Market Revenue and Volume Forecast
12.1. Immunochemistry Instruments and Reagents Market Revenue and Volume, by Test Type
12.1.1. Routine Testing
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Specialized Testing
12.1.2.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product
13.1.2. Market Revenue and Volume Forecast, by Technology
13.1.3. Market Revenue and Volume Forecast, by Application
13.1.4. Market Revenue and Volume Forecast, by End-Use
13.1.5. Market Revenue and Volume Forecast, by Test Type
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product
13.1.6.2. Market Revenue and Volume Forecast, by Technology
13.1.6.3. Market Revenue and Volume Forecast, by Application
13.1.6.4. Market Revenue and Volume Forecast, by End-Use
13.1.6.5. Market Revenue and Volume Forecast, by Test Type
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product
13.1.7.2. Market Revenue and Volume Forecast, by Technology
13.1.7.3. Market Revenue and Volume Forecast, by Application
13.1.7.4. Market Revenue and Volume Forecast, by End-Use
13.1.7.5. Market Revenue and Volume Forecast, by Test Type
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product
13.2.2. Market Revenue and Volume Forecast, by Technology
13.2.3. Market Revenue and Volume Forecast, by Application
13.2.4. Market Revenue and Volume Forecast, by End-Use
13.2.5. Market Revenue and Volume Forecast, by Test Type
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product
13.2.6.2. Market Revenue and Volume Forecast, by Technology
13.2.6.3. Market Revenue and Volume Forecast, by Application
13.2.7. Market Revenue and Volume Forecast, by End-Use
13.2.8. Market Revenue and Volume Forecast, by Test Type
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product
13.2.9.2. Market Revenue and Volume Forecast, by Technology
13.2.9.3. Market Revenue and Volume Forecast, by Application
13.2.10. Market Revenue and Volume Forecast, by End-Use
13.2.11. Market Revenue and Volume Forecast, by Test Type
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product
13.2.12.2. Market Revenue and Volume Forecast, by Technology
13.2.12.3. Market Revenue and Volume Forecast, by Application
13.2.12.4. Market Revenue and Volume Forecast, by End-Use
13.2.13. Market Revenue and Volume Forecast, by Test Type
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product
13.2.14.2. Market Revenue and Volume Forecast, by Technology
13.2.14.3. Market Revenue and Volume Forecast, by Application
13.2.14.4. Market Revenue and Volume Forecast, by End-Use
13.2.15. Market Revenue and Volume Forecast, by Test Type
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product
13.3.2. Market Revenue and Volume Forecast, by Technology
13.3.3. Market Revenue and Volume Forecast, by Application
13.3.4. Market Revenue and Volume Forecast, by End-Use
13.3.5. Market Revenue and Volume Forecast, by Test Type
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product
13.3.6.2. Market Revenue and Volume Forecast, by Technology
13.3.6.3. Market Revenue and Volume Forecast, by Application
13.3.6.4. Market Revenue and Volume Forecast, by End-Use
13.3.7. Market Revenue and Volume Forecast, by Test Type
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product
13.3.8.2. Market Revenue and Volume Forecast, by Technology
13.3.8.3. Market Revenue and Volume Forecast, by Application
13.3.8.4. Market Revenue and Volume Forecast, by End-Use
13.3.9. Market Revenue and Volume Forecast, by Test Type
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product
13.3.10.2. Market Revenue and Volume Forecast, by Technology
13.3.10.3. Market Revenue and Volume Forecast, by Application
13.3.10.4. Market Revenue and Volume Forecast, by End-Use
13.3.10.5. Market Revenue and Volume Forecast, by Test Type
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product
13.3.11.2. Market Revenue and Volume Forecast, by Technology
13.3.11.3. Market Revenue and Volume Forecast, by Application
13.3.11.4. Market Revenue and Volume Forecast, by End-Use
13.3.11.5. Market Revenue and Volume Forecast, by Test Type
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product
13.4.2. Market Revenue and Volume Forecast, by Technology
13.4.3. Market Revenue and Volume Forecast, by Application
13.4.4. Market Revenue and Volume Forecast, by End-Use
13.4.5. Market Revenue and Volume Forecast, by Test Type
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product
13.4.6.2. Market Revenue and Volume Forecast, by Technology
13.4.6.3. Market Revenue and Volume Forecast, by Application
13.4.6.4. Market Revenue and Volume Forecast, by End-Use
13.4.7. Market Revenue and Volume Forecast, by Test Type
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product
13.4.8.2. Market Revenue and Volume Forecast, by Technology
13.4.8.3. Market Revenue and Volume Forecast, by Application
13.4.8.4. Market Revenue and Volume Forecast, by End-Use
13.4.9. Market Revenue and Volume Forecast, by Test Type
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product
13.4.10.2. Market Revenue and Volume Forecast, by Technology
13.4.10.3. Market Revenue and Volume Forecast, by Application
13.4.10.4. Market Revenue and Volume Forecast, by End-Use
13.4.10.5. Market Revenue and Volume Forecast, by Test Type
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product
13.4.11.2. Market Revenue and Volume Forecast, by Technology
13.4.11.3. Market Revenue and Volume Forecast, by Application
13.4.11.4. Market Revenue and Volume Forecast, by End-Use
13.4.11.5. Market Revenue and Volume Forecast, by Test Type
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product
13.5.2. Market Revenue and Volume Forecast, by Technology
13.5.3. Market Revenue and Volume Forecast, by Application
13.5.4. Market Revenue and Volume Forecast, by End-Use
13.5.5. Market Revenue and Volume Forecast, by Test Type
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product
13.5.6.2. Market Revenue and Volume Forecast, by Technology
13.5.6.3. Market Revenue and Volume Forecast, by Application
13.5.6.4. Market Revenue and Volume Forecast, by End-Use
13.5.7. Market Revenue and Volume Forecast, by Test Type
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product
13.5.8.2. Market Revenue and Volume Forecast, by Technology
13.5.8.3. Market Revenue and Volume Forecast, by Application
13.5.8.4. Market Revenue and Volume Forecast, by End-Use
13.5.8.5. Market Revenue and Volume Forecast, by Test Type
14.1. Roche Diagnostics
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Danaher Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Siemens Healthineers
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Thermo Fisher Scientific
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bio-Rad Laboratories
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Sysmex Corporation
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Ortho Clinical Diagnostics
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Agilent Technologies
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. PerkinElmer
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at [email protected]
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client